These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 22536580

  • 1. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
    Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, Lauzon JL, Maltais F, O'Donnell DE, Goodridge D, Strange C, Cave AJ, Curren K, Muthuri S, Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group.
    Can Respir J; 2012; 19(2):109-16. PubMed ID: 22536580
    [Abstract] [Full Text] [Related]

  • 2. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F.
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [Abstract] [Full Text] [Related]

  • 3. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S, Welte T.
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [Abstract] [Full Text] [Related]

  • 4. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK, Mosley JD, Rao DC, Palmer LJ, Province MA, Elston RC, Weiss ST, Campbell EJ.
    Hum Hered; 2001 Aug; 52(4):223-32. PubMed ID: 11713419
    [Abstract] [Full Text] [Related]

  • 5. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF, Miravitlles M.
    Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837
    [Abstract] [Full Text] [Related]

  • 6. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI, Mumford RA, Treonze KM, Finke PE, Davies P, Si Q, Humes JL, Dirksen A, Piitulainen E, Ahmad A, Stockley RA.
    Thorax; 2011 Aug 30; 66(8):686-91. PubMed ID: 21617168
    [Abstract] [Full Text] [Related]

  • 7. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC, Crystal RG.
    Am J Med; 1988 Jun 24; 84(6A):52-62. PubMed ID: 3289387
    [Abstract] [Full Text] [Related]

  • 8. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun 24; 12():1295-1308. PubMed ID: 28496314
    [Abstract] [Full Text] [Related]

  • 9. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
    Topic A, Milovanovic V, Lazic Z, Ivosevic A, Radojkovic D.
    COPD; 2018 Oct 24; 15(5):472-478. PubMed ID: 30822244
    [Abstract] [Full Text] [Related]

  • 10. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R, Hilberg O, Løkke A, Pedersen L, Ringbæk T, Titlestad I.
    Ugeskr Laeger; 2011 Oct 17; 173(42):2645-7. PubMed ID: 22027165
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
    Parr DG, Lara B.
    Drug Des Devel Ther; 2017 Oct 17; 11():2149-2162. PubMed ID: 28769553
    [Abstract] [Full Text] [Related]

  • 12. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA.
    Expert Opin Emerg Drugs; 2010 Dec 17; 15(4):685-94. PubMed ID: 20716026
    [Abstract] [Full Text] [Related]

  • 13. Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.
    Stoller JK, Fallat R, Schluchter MD, O'Brien RG, Connor JT, Gross N, O'Neil K, Sandhaus R, Crystal RG.
    Chest; 2003 May 17; 123(5):1425-34. PubMed ID: 12740257
    [Abstract] [Full Text] [Related]

  • 14. Alpha 1-antitrypsin-deficiency-related emphysema.
    Barker AF.
    J Am Board Fam Pract; 1992 May 17; 5(5):489-93. PubMed ID: 1414450
    [Abstract] [Full Text] [Related]

  • 15. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
    Rahaghi FF, Monk R, Ramakrishnan V, Beiko T, Strange C.
    Int J Chron Obstruct Pulmon Dis; 2020 May 17; 15():3193-3199. PubMed ID: 33299307
    [Abstract] [Full Text] [Related]

  • 16. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA, Lascano J.
    Ther Adv Respir Dis; 2014 Oct 17; 8(5):150-61. PubMed ID: 25013223
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
    Petrache I, Hajjar J, Campos M.
    Biologics; 2009 Oct 17; 3():193-204. PubMed ID: 19707408
    [Abstract] [Full Text] [Related]

  • 18. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT, Ford GT, Chapman KR, Stnadards Committee of the Canadian Thoracic Society.
    Can Respir J; 2001 Oct 17; 8(2):81-8. PubMed ID: 11320399
    [Abstract] [Full Text] [Related]

  • 19. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG, RAPID Trial Study Group.
    Lancet; 2015 Jul 25; 386(9991):360-8. PubMed ID: 26026936
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians, American College of Chest Physicians, American Thoracic Society, European Respiratory Society.
    Ann Intern Med; 2011 Aug 02; 155(3):179-91. PubMed ID: 21810710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.